Quality of Life of Women After a First Diagnosis of Breast Cancer Using a Self-Management Support mHealth App in Taiwan: Randomized Controlled Trial

I-Ching Hou, Hsin-Yi Lin, Shan-Hsiang Shen, King-Jen Chang, Hao-Chih Tai, Ay-Jen Tsai, Patricia C Dykes, I-Ching Hou, Hsin-Yi Lin, Shan-Hsiang Shen, King-Jen Chang, Hao-Chih Tai, Ay-Jen Tsai, Patricia C Dykes

Abstract

Background: There are over 2 million newly diagnosed patients with breast cancer worldwide with more than 10,000 cases in Taiwan each year. During 2017-2018, the National Yang-Ming University, the Taiwan University of Science and Technology, and the Taiwan Breast Cancer Prevention Foundation collaborated to develop a breast cancer self-management support (BCSMS) mHealth app for Taiwanese women with breast cancer.

Objective: The aim of this study was to investigate the quality of life (QoL) of women with breast cancer in Taiwan after using the BCSMS app.

Methods: After receiving a first diagnosis of breast cancer, women with stage 0 to III breast cancer, who were recruited from social networking sites or referred by their oncologists or oncology case managers, were randomized 1:1 into intervention and control groups. Intervention group subjects used the BCSMS app and the control group subjects received usual care. Two questionnaires-the European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life Questionnaire Core 30 (QLQ-C30) and the EORTC Breast Cancer-Specific Quality-of-Life Questionnaire (QLQ-BR23)-were distributed to subjects in both arms. Paper-based questionnaires were used at baseline; paper-based or Web-based questionnaires were used at 1.5-month and 3-month follow-up evaluations. All evaluations were self-assessed and anonymous, and participants were blinded to their allocation groups. Descriptive analysis, the Pearson chi-square test, analysis of variance, and the generalized estimating equation were used to analyze the data. Missing values, with and without multi-imputation techniques, were used for sensitivity analysis.

Results: A total of 112 women were enrolled and randomly allocated to either the experimental group (n=53) or control group (n=59). The follow-up completion rate was 89.3% (100/112). The demographic data showed homogeneity between the two groups in age (range 50-64 years), breast cancer stage (stage II), marital status (married), working status (employed), and treatment status (receiving treatments). The mean total QoL summary scores from the QLQ-C30 (83.45 vs 82.23, P=.03) and the QLQ-BR23 (65.53 vs 63.13, P=.04) were significantly higher among the experimental group versus the control group, respectively, at 3 months.

Conclusions: This research provides support for using a mobile health care app to promote the QoL among women in Taiwan after a first diagnosis of breast cancer. The BCSMS app could be used to support disease self-management, and further evaluation of whether QoL is sustained is warranted.

Trial registration: ClinicalTrials.gov NCT004174248; https://ichgcp.net/clinical-trials-registry/NCT04174248.

Keywords: breast cancer; mHealth app; quality of life; self-management.

Conflict of interest statement

Conflicts of Interest: None declared.

©I-Ching Hou, Hsin-Yi Lin, Shan-Hsiang Shen, King-Jen Chang, Hao-Chih Tai, Ay-Jen Tsai, Patricia C Dykes. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 04.03.2020.

Figures

Figure 1
Figure 1
Study flowchart.

References

    1. Health Promotion Administration . Cancer Registry Annual Report, 2015. Taipei, Taiwan: Ministry of Health and Welfare; 2017. [2019-10-08]. .
    1. Health Promotion Administration . Cancer Registry Annual Report, 2016. Taipei, Taiwan: Ministration of Health and Welfare; 2018. Dec, [2019-12-30]. .
    1. Lin CH. Chemotherapy in breast cancer. Formos J Med. 2013;17(4):404–411. doi: 10.6320/fjm.2013.17(4).08.
    1. Matsen CB, Neumayer LA. Breast cancer: A review for the general surgeon. JAMA Surg. 2013 Oct;148(10):971–979. doi: 10.1001/jamasurg.2013.3393.
    1. Diaby V, Tawk R, Sanogo V, Xiao H, Montero AJ. A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer. Breast Cancer Res Treat. 2015 May;151(1):27–40. doi: 10.1007/s10549-015-3383-6.
    1. Lo C, Liao FZ, Chen SL. Symptom experiences of breast cancer patients. J Nurs. 2017;64(2):19–27. doi: 10.6224/jn.000021.
    1. Browall M, Brandberg Y, Nasic S, Rydberg P, Bergh J, Rydén A, Xie H, Eriksson I, Wengström Y. A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatment. Support Care Cancer. 2017 May;25(5):1423–1429. doi: 10.1007/s00520-016-3527-1.
    1. Hermelink K, Bühner M, Sckopke P, Neufeld F, Kaste J, Voigt V, Münzel K, Wuerstlein R, Ditsch N, Hellerhoff K, Rjosk-Dendorfer D, Braun M, von Koch FE, Härtl K, Hasmüller S, Bauerfeind I, Debus G, Herschbach P, Mahner S, Harbeck N. Chemotherapy and post-traumatic stress in the causation of cognitive dysfunction in breast cancer patients. J Natl Cancer Inst. 2017 Oct 01;109(10):1–15. doi: 10.1093/jnci/djx057.
    1. Wiśniewska I, Jochymek B, Lenart-Lipińska M, Chabowski M. The pharmacological and hormonal therapy of hot flushes in breast cancer survivors. Breast Cancer. 2016 Mar;23(2):178–182. doi: 10.1007/s12282-015-0655-2.
    1. Savard J, Ivers H, Savard M, Morin CM. Cancer treatments and their side effects are associated with aggravation of insomnia: Results of a longitudinal study. Cancer. 2015 May 15;121(10):1703–1711. doi: 10.1002/cncr.29244. doi: 10.1002/cncr.29244.
    1. Jung MS, Cimprich B. Cognitive deficits in Korean women treated with chemotherapy for breast cancer. Cancer Nurs. 2014;37(3):E31–E42. doi: 10.1097/ncc.0b013e3182980383.
    1. Yee C, Wang K, Asthana R, Drost L, Lam H, Lee J, Vesprini D, Leung E, DeAngelis C, Chow E. Radiation-induced skin toxicity in breast cancer patients: A systematic review of randomized trials. Clin Breast Cancer. 2018 Oct;18(5):e825–e840. doi: 10.1016/j.clbc.2018.06.015.
    1. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: A review. Patient Educ Couns. 2002 Oct;48(2):177–187. doi: 10.1016/s0738-3991(02)00032-0.
    1. McCorkle R, Ercolano E, Lazenby M, Schulman-Green D, Schilling LS, Lorig K, Wagner EH. Self-management: Enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin. 2011;61(1):50–62. doi: 10.3322/caac.20093. doi: 10.3322/caac.20093.
    1. Li MF, Pan LC. Applications on mobile health. J Long Term Care. 2012;16(3):237–250.
    1. Kuo CC, Wang HH. Applying self-management intervention studies to patients with chronic illness: A systematic review. J Nurs Healthc Res. 2012;8(1):50–60. doi: 10.6225/jnhr.8.1.52.
    1. Loh SY, Packer T, Chinna K, Quek KF. Effectiveness of a patient self-management programme for breast cancer as a chronic illness: A non-randomised controlled clinical trial. J Cancer Surviv. 2013 Sep;7(3):331–342. doi: 10.1007/s11764-013-0274-x.
    1. World Health Organization. 2019. Dec, [2019-12-12]. WHOQOL: Measuring quality of life
    1. Tsai H, Kuo NC, Chung KP. Quality of life of breast cancer survivors following breast-conserving therapy versus mastectomy: A multicenter study in Taiwan. Jpn J Clin Oncol. 2017 Oct 01;47(10):909–918. doi: 10.1093/jjco/hyx099.
    1. Fanakidou I, Zyga S, Alikari V, Tsironi M, Stathoulis J, Theofilou P. Mental health, loneliness, and illness perception outcomes in quality of life among young breast cancer patients after mastectomy: The role of breast reconstruction. Qual Life Res. 2018 Feb;27(2):539–543. doi: 10.1007/s11136-017-1735-x.
    1. Hamer J, McDonald R, Zhang L, Verma S, Leahey A, Ecclestone C, Bedard G, Pulenzas N, Bhatia A, Chow R, DeAngelis C, Ellis J, Rakovitch E, Lee J, Chow E. Quality of life (QOL) and symptom burden (SB) in patients with breast cancer. Support Care Cancer. 2017 Feb;25(2):409–419. doi: 10.1007/s00520-016-3417-6.
    1. Kessel KA, Vogel MM, Kessel C, Bier H, Biedermann T, Friess H, Herschbach P, von Eisenhart-Rothe R, Meyer B, Kiechle M, Keller U, Peschel C, Schmid RM, Combs SE. Mobile health in oncology: A patient survey about app-assisted cancer care. JMIR Mhealth Uhealth. 2017 Jun 14;5(6):e81. doi: 10.2196/mhealth.7689.
    1. Kessel KA, Vogel MM, Schmidt-Graf F, Combs SE. Mobile apps in oncology: A survey on health care professionals' attitude toward telemedicine, mHealth, and oncological apps. J Med Internet Res. 2016 Nov 24;18(11):e312. doi: 10.2196/jmir.6399.
    1. Zhu J, Ebert L, Guo D, Yang S, Han Q, Chan SW. Mobile breast cancer e-support program for Chinese women with breast cancer undergoing chemotherapy (Part 1): Qualitative study of women's perceptions. JMIR Mhealth Uhealth. 2018 Apr 11;6(4):e85. doi: 10.2196/mhealth.9311.
    1. Rincon E, Monteiro-Guerra F, Rivera-Romero O, Dorronzoro-Zubiete E, Sanchez-Bocanegra CL, Gabarron E. Mobile phone apps for quality of life and well-being assessment in breast and prostate cancer patients: Systematic review. JMIR Mhealth Uhealth. 2017 Dec 04;5(12):e187. doi: 10.2196/mhealth.8741.
    1. Giunti G, Giunta D, Guisado-Fernandez E, Bender J, Fernandez-Luque L. A biopsy of breast cancer mobile applications: State of the practice review. Int J Med Inform. 2018 Feb;110:1–9. doi: 10.1016/j.ijmedinf.2017.10.022.
    1. Lee H, Uhm KE, Cheong IY, Yoo JS, Chung SH, Park YH, Lee JY, Hwang JH. Patient satisfaction with mobile health (mHealth) application for exercise intervention in breast cancer survivors. J Med Syst. 2018 Nov 06;42(12):254. doi: 10.1007/s10916-018-1096-1.
    1. World Medical Association World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013 Nov 27;310(20):2191–2194. doi: 10.1001/jama.2013.281053.
    1. Wildenbos GA, Peute L, Jaspers M. Aging barriers influencing mobile health usability for older adults: A literature based framework (MOLD-US) Int J Med Inform. 2018 Jun;114:66–75. doi: 10.1016/j.ijmedinf.2018.03.012.
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edition. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988. The analysis of variance and covariance; pp. 273–406.
    1. Day SJ, Altman DG. Statistics notes: Blinding in clinical trials and other studies. BMJ. 2000;321(7259):504. doi: 10.1136/bmj.321.7259.504.
    1. Persaud N, Heneghan C, Catalogue of Bias Collaboration Catalogue of Bias. [2019-12-21]. Novelty bias
    1. . [2018-12-01]. .
    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 03;85(5):365–376. doi: 10.1093/jnci/85.5.365.
    1. EORTC Quality of Life. [2019-08-02]. Questionnaires: Breast
    1. Chie W, Chang K, Huang C, Kuo W. Quality of life of breast cancer patients in Taiwan: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23. Psychooncology. 2003;12(7):729–735. doi: 10.1002/pon.727.
    1. Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, Cull A, Aaronson NK. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: First results from a three-country field study. J Clin Oncol. 1996 Oct;14(10):2756–2768. doi: 10.1200/JCO.1996.14.10.2756.
    1. Fayers P, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 Scoring Manual. 3rd edition. Brussels, Belgium: European Organisation for Research and Treatment of Cancer; 2001.
    1. Noyes JM, Garland KJ. Computer- vs paper-based tasks: Are they equivalent? Ergonomics. 2008 Sep;51(9):1352–1375. doi: 10.1080/00140130802170387.
    1. Henson RK. Understanding internal consistency reliability estimates: A conceptual primer on coefficient alpha. Meas Eval Couns Dev. 2019 Aug 29;34(3):177–189. doi: 10.1080/07481756.2002.12069034.
    1. Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis. 2nd edition. Hoboken, NJ: John Wiley & Sons; 2011. Missing data and dropout: Multiple imputation and weighting methods; pp. 515–550.
    1. Twisk J, de Vente W. Attrition in longitudinal studies. J Clin Epidemiol. 2002 Apr;55(4):329–337. doi: 10.1016/S0895-4356(01)00476-0. doi: 10.1016/s0895-4356(01)00476-0.
    1. Schulz KF, Altman DG, Moher D, CONSORT Group CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMC Med. 2010 Mar 24;8:18. doi: 10.1186/1741-7015-8-18.
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edition. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988. The concepts of power analysis; pp. 1–17.
    1. Koch L, Jansen L, Herrmann A, Stegmaier C, Holleczek B, Singer S, Brenner H, Arndt V. Quality of life in long-term breast cancer survivors: A 10-year longitudinal population-based study. Acta Oncol. 2013 Mar 20;52(6):1119–1128. doi: 10.3109/0284186x.2013.774461.
    1. Farzandipour M, Nabovati E, Sharif R, Arani MH, Anvari S. Patient self-management of asthma using mobile health applications: A systematic review of the functionalities and effects. Appl Clin Inform. 2017 Oct;8(4):1068–1081. doi: 10.4338/ACI-2017-07-R-0116.
    1. Rathbone AL, Prescott J. The use of mobile apps and SMS messaging as physical and mental health interventions: Systematic review. J Med Internet Res. 2017 Aug 24;19(8):e295. doi: 10.2196/jmir.7740.
    1. Duke DC, Barry S, Wagner DV, Speight J, Choudhary P, Harris MA. Distal technologies and type 1 diabetes management. Lancet Diabetes Endocrinol. 2018 Feb;6(2):143–156. doi: 10.1016/S2213-8587(17)30260-7.
    1. Zhu J, Ebert L, Liu X, Wei D, Chan SW. Mobile breast cancer e-support program for Chinese women with breast cancer undergoing chemotherapy (Part 2): Multicenter randomized controlled trial. JMIR Mhealth Uhealth. 2018 Apr 30;6(4):e104. doi: 10.2196/mhealth.9438.
    1. Harder H, Holroyd P, Burkinshaw L, Watten P, Zammit C, Harris PR, Good A, Jenkins V. A user-centred approach to developing bWell, a mobile app for arm and shoulder exercises after breast cancer treatment. J Cancer Surviv. 2017 Dec;11(6):732–742. doi: 10.1007/s11764-017-0630-3.
    1. Cruz FOAM, Vilela RA, Ferreira EB, Melo NS, Reis PEDD. Evidence on the use of mobile apps during the treatment of breast cancer: Systematic review. JMIR Mhealth Uhealth. 2019 Aug 27;7(8):e13245. doi: 10.2196/13245.
    1. Hou IC, Lan MF, Shen SH, Tsai PY, Chang KJ, Tai HC, Tsai AJ, Chang C, Wang TF, Sheu SJ, Dykes PC. Developing a breast cancer self-management support mHealth application in Taiwan: A design thinking approach [In press] JMIR mHealth and uHealth. 2020 doi: 10.2196/15780. (forthcoming)
    1. Foley N, O'Connell E, Lehane E, Livingstone V, Maher B, Kaimkhani S, Cil T, Relihan N, Bennett M, Redmond H, Corrigan M. PATI: Patient accessed tailored information: A pilot study to evaluate the effect on preoperative breast cancer patients of information delivered via a mobile application. Breast. 2016 Dec;30:54–58. doi: 10.1016/j.breast.2016.08.012.
    1. van Vulpen JK, Peeters PH, Velthuis MJ, van der Wall E, May AM. Effects of physical exercise during adjuvant breast cancer treatment on physical and psychosocial dimensions of cancer-related fatigue: A meta-analysis. Maturitas. 2016 Mar;85:104–111. doi: 10.1016/j.maturitas.2015.12.007.
    1. van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, de Maaker-Berkhof M, Boven E, Schrama J, Geenen MM, Meerum Terwogt JM, van Bochove A, Lustig V, van den Heiligenberg SM, Smorenburg CH, Hellendoorn-van Vreeswijk JA, Sonke GS, Aaronson NK. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: Results of the PACES randomized clinical trial. J Clin Oncol. 2015 Jun 10;33(17):1918–1927. doi: 10.1200/JCO.2014.59.1081.
    1. Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, Schrag D. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017 Jul 11;318(2):197–198. doi: 10.1001/jama.2017.7156.
    1. McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P. The Hawthorne Effect: A randomised, controlled trial. BMC Med Res Methodol. 2007 Jul 03;7:30. doi: 10.1186/1471-2288-7-30.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe